ESOPHAGEAL CANCER (ESC)
Clinical trials for ESOPHAGEAL CANCER (ESC) explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL CANCER (ESC) trials appear
Sign up with your email to follow new studies for ESOPHAGEAL CANCER (ESC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for esophageal cancer treatment
Disease control Recruiting nowThis study is testing a drug called adebrelimab (SHR-1316) combined with chemotherapy for people with a type of esophageal cancer that can be surgically removed. The treatment is given before and after surgery to see if it helps shrink tumors and prevent cancer from coming back. …
Matched conditions: ESOPHAGEAL CANCER (ESC)
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
New study aims to uncover hidden clues to beat esophageal cancer
Knowledge-focused Recruiting nowThis study follows 100 people newly diagnosed with esophageal cancer to learn how their heart health, nutrition, and physical fitness change during treatment. Researchers will use non-invasive tests like heart MRIs and CT scans, along with questionnaires, to find factors that can…
Matched conditions: ESOPHAGEAL CANCER (ESC)
Sponsor: Semmelweis University • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC